By providing access to natural daylight and a visual connection with the external environment, glass ensures health and well-being in all type of buildings.
Before a drug makes it onto the market it is vigorously tested and needs to be authorized, either by a national competent authority or EMA, the European Medicines Agency. All the information on when a medicinal product can and cannot be …
People living with SMA, ALS and other rare disease was the focus of the Rare Disease event at the EU Parliament on 18 February. The event was organised by Biogen in collaboration with EURORDIS, the patient organisation for rare diseases.
A global paradigm shift is occurring in attitudes towards economic and social progress. From a GDP centred model, a new paradigm now focuses on improving citizen's well-being. All Policies for a Healthy Europe is a multi-stakeholder initiative calling for Europe …
As part of the European Biotech Week, Johnson & Johnson hosted a exclusive roundtable discussion on "Life Science Investments in Europe" in Brussels.
The European Commission adopted in June 2017 a new Action Plan to tackle Antimicrobial Resistance (AMR), responsible for 25,000 deaths and a loss of €1.5bn in the EU every year.
In an interview with EURACTIV, Ethiopian Minister of Health Dr. Kesetebirhan Admasu described the impressive improvements of healthcare in his country over the last years, stressing that the reforms have been designed and implemented without following foreign prescriptions.
Chronic diseases such as cardiovascular diseases are responsible for 86% of all deaths in Europe, siphoning off 70% to 80% of healthcare budgets – an estimated €700 billion per year. During the 2014 EU Summit on Chronic Diseases, the European Commission identified key actions to tackle those. The initiative was taken in response to a call by the United Nations to reduce Non Communicable Diseases by 25% by 2025.
So-called “bad” cholesterol increases the risks of heart diseases and stroke. According to the WHO, globally, a third of ischaemic heart disease is attributable to high cholesterol.
The 2014 Euro Diabetes Index was presented at the 50th Congress of the European Association for the Study of Diabetes (EASD) in Vienna. It is a tool for awareness and advocacy at national and European level to empower patients and physicians through comparing and reviewing health care provision and policies regarding diabetes in all member states plus Norway and Switzerland.
In his confirmation hearing at the European Parliament in Brussels on Tuesday, Lithuanian Commissioner-designate for Health and Food Safety Vytenis Andriukaitis said that “supporting universal health coverage, strengthening primary care, improving quality and safety, promoting e-health” will be among his priorities.
On Saturday, more than ten thousand people gathered at the special Olympics’ opening ceremony in Belgium, where athletes with intellectual disabilities will compete over the coming days.
This first EU summit on chronic diseases discussed medical, social and economic benefits of sustainable investments in health, ways to reduce the burden of chronic diseases, and how to strengthen the prevention and management of chronic diseases, with a focus on EU added value and action.
African governments are increasingly investing in healthcare, but their progress in preventing infectious diseases could be set back without financial support from the EU and other donors.
The healthcare sector is among the rare ones where demand for labour is increasing, according to the European Vacancy Monitor (EVM), a quarterly bulletin published by the European Commission's Employment directorate.
Adherence is more than taking medication regularly. Adherence is about personal lifestyle goals and choices, DMD treatment choices, rehabilitation and symptomatic treatment choices, vocational choices, relationship and family choices in a setting of multiple uncertainties and risks as person with Multiple Sclerosis.
Assessment of existing knowledge and experiences in adherence in a chronic disease and the development of a joint proposal by the gathered panel of experts on further actions in this field -- these are the two main aims of ADAMS.
Several European Commission 2012 initiatives will impact healthcare innovation. The Horizon 2020 research programme will seek to link the health industry, public sector and academia in new research clusters. A revision to the Directive on Clinical Trials will seek to promote health research and innovation. Meanwhile, the Transparency Directive will ensure that research efforts translate into faster access to much- needed medicines.
